CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $93.37 ($280,101)
- 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $95.35 ($1,239,608)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 45,626 shares at $90.07 ($4,109,534)
- 4 Open-market sale Chief Executive Officer sold 49,374 shares at an average $90.40 ($4,463,524)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $85.76 ($175,808)
- 4 Open-market sale Chief Scientific Officer sold 15,177 shares at $90.00 ($1,365,930)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $85.00 ($170,003)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at $81.38 ($162,760)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at $81.81 ($245,430)
- 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $83.04 ($1,079,501)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $85.95 ($176,198)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $85.10 ($170,190)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $75.20 ($225,607)
Page 21 of 38 · 758 filings